Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
GSK963 is an inhibitor of receptor-interacting serine/threonine kinase 1 (RIPK1).1 It is selective for RIPK1 with less than 50% inhibition of 339 kinases in a panel at 10 µM. Unlike the RIPK1 inhibitor necrostatin-1 (Item No. 11658), GSK963 is inactive against indolamine-2,3-dioxygenase (IDO). GSK963 inhibits necroptosis induced by TNF in the presence of the caspase inhibitor zVAD in L-929 mouse and U937 human cells (IC50s = 1 and 4 nM, respectively). It also inhibits RIPK1-mediated lethal hypothermia induced by TNF with zVAD in mice when administered at a dose of 2 mg/kg in a model of sterile shock.
WARNING This product is not for human or veterinary use.
1. Characterization of GSK'963: A structurally distinct, potent and selective inhibitor of RIP1 kinase. Cell Death Discov. 1, 15009 (2015).